HHS Awards $47 Million to 15 Organizations to Evaluate Chronic Disease Prevention Strategies for Medicare Through MAHA ELEVATE
-
By
-
Assistant Secretary for Public Affairs (ASPA)
-
November 20, 2026
Clinical Report: HHS Awards $47 Million for Medicare Chronic Disease Strategies
Overview
HHS reported that CMS awarded $47 million to 15 organizations through the MAHA ELEVATE Model to evaluate lifestyle and functional medical interventions for chronic disease prevention and management among Medicare beneficiaries. The model will assess care quality and costs; each selected proposal includes nutrition or physical activity.
Background
Chronic diseases identified in the announcement include heart failure, dementia, diabetes, obesity, and hypertension. HHS stated that chronic disease accounts for 90% of U.S. healthcare spending. MAHA ELEVATE will test interventions intended to complement conventional medical care and measure outcomes and costs. CMS said the evaluation will inform which approaches may be suitable for wider implementation.
Data Highlights
| Measure | Reported information |
|---|---|
| Funding awarded | $47 million |
| Organizations selected | 15 |
| Applications received | Nearly 450 |
| Conditions addressed | Heart failure, dementia, diabetes, obesity, and hypertension |
| Chronic disease share of U.S. healthcare spending | 90%, as stated in the announcement |
| Planned future awards | CMS intends to issue a new Notice of Funding Opportunity in 2027 for as many as 15 awards |
Key Findings
- The 15 awards support evaluation of chronic disease prevention and management strategies for Medicare beneficiaries.
- CMS selected awardees through a competitive merit review that assessed evaluability, policy compliance, clinical soundness, and potential for cost savings.
- All selected proposals incorporate nutrition or physical activity.
- Project examples include dietitian coaching, community health worker support, and remote home blood pressure monitoring with clinician alerts.
- Other projects include occupational therapy assistant sessions for beneficiaries with diabetes or cardiovascular risk, fall-prevention education for people with cognitive impairment, and a virtual behavioral lifestyle intervention for people with obesity and hypertension.
- The CMS MAHA ELEVATE fact sheet describes the model as funding evidence-based lifestyle and functional interventions not typically covered by Original Medicare; CMS also describes the Medicare Diabetes Prevention Program as an existing prevention initiative.
Clinical Implications
The announcement describes an evaluation initiative, not results demonstrating that the funded interventions improve outcomes or reduce costs. CMS plans to measure outcomes and costs to identify approaches that may support lasting changes among Medicare beneficiaries and may be appropriate for wider implementation.
Conclusion
MAHA ELEVATE will evaluate 15 organizations’ lifestyle and functional intervention projects for Medicare beneficiaries, with a focus on chronic disease outcomes and costs. The announcement reports that CMS plans to use the evaluation to inform potential wider implementation.
Related Resources & Content
- U.S. Department of Health and Human Services, Press release, 2026 — HHS Awards $47 Million to 15 Organizations to Evaluate Chronic Disease Prevention Strategies for Medicare Through MAHA ELEVATE
- Centers for Medicare & Medicaid Services, Fact sheet, year not specified — MAHA ELEVATE Overview Fact Sheet
- American Diabetes Association, Standards of Care in Diabetes—2026, 2026 — Prevention or Delay of Diabetes and Associated Comorbidities
- U.S. Department of Health and Human Services, 2026 — HHS Commits Up to $27.8 Million to Expand Falls Prevention Programs
- United States Department of Health and Human Services — HHS Allocates Almost $25 Million to Enhance Small Rural Hospitals and Ensure Continued Access to Healthcare
- United States Department of Health and Human Services — HHS Unveils Major Funding Initiative to Enhance Health Center Program, Increasing Primary Care Access for Nearly 1 Million Americans
- Journal of Medical Internet Research (JMIR) — Centers for Medicare & Medicaid Services to Launch Landmark ACCESS Program
- MAHA ELEVATE Model — CMS
- MAHA ELEVATE Overview Fact Sheet — CMS
- Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2026
- MAHA ELEVATE Overview Fact Sheet
- 3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2026
- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Based on findings from:
HHS Announces $47 Million in MAHA ELEVATE Awards to 15 Organizations to Test Chronic Disease Prevention Approaches in Medicare
Assistant Secretary for Public Affairs (ASPA). United States Department Of Health And Human Services, 2026.
https://www.hhs.gov/press-room/hhs-awards-47-million-maha-elevate-medicare-chronic-disease-prevention.html
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.